The company said this will help formula manufacturers reduce energy usage and production costs without compromising on safety or quality.
Lacprodan MFGM-10, which is rich in phospholipids and gangliosides, was the first MFGM ingredient for the global infant formula market.
The new dry-blend option – Lacprodan Premium MFGM-10, uses dry-blending, a process that allows manufacturers to reduce energy usage and production costs. It also provides greater flexibility to produce more recipes from one base powder.
Also, the dry-blending process requires particularly high microbiological compliance throughout the entire batch of the ingredient, which ensures consistent quality and product safety. Arla Foods Ingredients said this also means Lacprodan Premium MFGM-10 is free from Cronobacter sakazakii, a bacterium that can cause serious infections in infants.
Niels Joakim Karlsen, pediatric sales development manager at Arla Foods Ingredients, said, “MFGM is a key ingredient for the global formula market. By offering Lacprodan MFGM-10 in a dry blend form, we’re combining the clinically proven benefits of this ingredient with opportunities to reduce energy usage and production costs while ensuring high quality and product safety.”